Q3 EPS Estimate for SAB Biotherapeutics Boosted by Analyst

Дата публикации: 10-08-2026 05:44:45

SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – Brookline Capital Markets upped their Q3 2026 earnings estimates for SAB Biotherapeutics in a research report issued to clients and investors on Thursday, August 6th. Brookline Capital Markets analyst K. Raja now expects that the company will post earnings of ($0.24) per share for the quarter, up […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	HC Wainwright Issues Pessimistic Outlook for SABS Earnings	0	12.58	10-08-2026
2	XFOR FY2029 EPS Boosted by Brookline Capital Markets	0	12.66	10-08-2026
3	Zacks Research Analysts Increase Earnings Estimates for ARWR	0	11.84	10-08-2026
4	Zacks Research Lifts Earnings Estimates for Bread Financial	0	11.13	10-08-2026
5	FY2026 EPS Estimates for Jacobs Solutions Raised by KeyCorp	0	11.18	10-08-2026
6	Satellogic Q1 EPS Estimate Increased by Northland Securities	0	12.58	10-08-2026
7	FY2029 Earnings Forecast for IN8bio Issued By HC Wainwright	0	14.81	10-08-2026
8	Brokers Set Expectations for Galaxy Digital Q3 Earnings	0	11.84	10-08-2026
9	Erste Group Bank Expects Stronger Earnings for UBS Group	0	10.45	10-08-2026
10	Geo Group Q3 EPS Estimate Boosted by Northland Securities	0	11.83	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.83. Источник: www.americanbankingnews.com.